WHO ICTRP trial
A multicenter, randomized, double-blind, double-simulation, positive drug…
ChiCTR2300078935 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2300078935 |
|---|---|
| Public title | A multicenter, randomized, double-blind, double-simulation, positive drug parallel controlled clinical trial of Heng-Gu-Gu-Shang-Yu-He-Ji for the treatment of lumbar disc herniation |
| Scientific title | A multicenter, randomized, double-blind, double-simulation, positive drug parallel controlled clinical trial of Heng-Gu-Gu-Shang-Yu-He-Ji for the treatment of lumbar disc herniation |
| Primary sponsor | The Third Affiliated Hospital of Beijing University of Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Lumbar disc herniation |
| Interventions | Test group:Heng-Gu-Gu-Shang-Yu-He-Ji+Yaobitong Capsule Simulator;control group:Heng-Gu-Gu-Shang-Yu-He-Ji Simulator+Yaobitong Capsules |
| Registration date | Dec 21, 2023 |
| Target size | Test group:148;control group:74 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: